Targeting DNA Replication Stress for Cancer Therapy

Area of Science:

• Genomic integrity and DNA damage response in cancer biology.
• Cellular mechanisms of replication stress and its role in tumorigenesis.

Background:

• Normal cells maintain genomic stability through DNA damage response (DDR) pathways, involving DNA repair, apoptosis, or senescence.
• Cancer cells often have defective DDR and constitutive growth signaling, leading to unique "replication stress" characterized by impaired DNA replication.

Purpose of the Study:

• To review the rationale for exploiting cancer cells' defective DDR by enhancing replication stress.
• To discuss traditional and emerging therapeutic strategies targeting DNA damage and replication stress signaling.
• To summarize current clinical trials and propose future research directions.

Main Methods:

• Review of existing literature on DNA damage response, replication stress, and cancer therapeutics.
• Analysis of past approaches (radiation, chemotherapy) and emerging targeted therapies.
• Summary of ongoing clinical trials and identification of future research needs.

Main Results:

• Replication stress, while inducing genomic instability, can be therapeutically leveraged in cancer.
• Targeting DNA damage signaling cascades presents emerging therapeutic opportunities.
• Combination therapies and biomarker identification are crucial for optimizing treatments.

Conclusions:

• Enhancing replication stress in cancer cells is a viable therapeutic strategy due to their compromised DDR.
• Targeting DNA damage response pathways and replication stress offers new avenues for cancer treatment.
• Future research should focus on combination therapies and biomarkers for personalized treatment strategies.